# Clearside Biomedical
 (stock symbol: CLSD) Logo in transparent PNG format

## Clearside Biomedical
 Logo large

### Clearside Biomedical
 Logo large Download PNG (61.93 KB)

![Clearside Biomedical
 Logo large Download PNG (61.93 KB)](/img/orig/CLSD_BIG-2c41e55e.png)

## Clearside Biomedical
 Logo icon format

### Clearside Biomedical
 Logo icon format Download PNG (64.44 KB)

![Clearside Biomedical
 Logo icon format Download PNG (64.44 KB)](/img/orig/CLSD-d3685444.png)

## About Clearside Biomedical


Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an integrin inhibitor suspension for the treatment of diabetic macular edema and macular degeneration. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.

1. Website domain: clearsidebio.com
2. Employees: 34
3. Marketcap: $61.97 Million USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
